Pathelium

Pathelium is a pioneering biotech startup focused on unlocking the regenerative potential of epithelial tissues to treat and cure chronic diseases. Our science is built on the insight that over 70% of chronic diseases (such as IBP,COPD, and fibrosis) begin with epithelial dysfunction—the body's first line of defense across the skin, lungs, and intestines. Where big pharmas treat symptoms, generic stem cells lack precision, and tissue engineers miss function, we are pioneering in rebuilding the body's critical barrier to cure disease, not manage it.